Create Alert
Watchlist

Zydus Lifesciences

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹98,007Cr
ROE18.89%
P/E Ratio(TTM)21.66
EPS(TTM)44.97
P/B Ratio4.09
Dividend Yield1.13%
Industry P/E34.88
Book Value238.05
Debt to Equity0.13
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Zydus Lifesciences

Zydus Lifesciences Ltd. is an India-based life sciences company. The Company is engaged in the research and development, manufacturing, marketing and selling of finished dosage human formulations, such as generics and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients (APIs); animal healthcare products, and consumer wellness products. Its products include Bilypsa (saroglitizar), Oxemia (desidustat), Ujvira (biosimilar Kadcyla), and Exemptia. It offers Bilypsa drug for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Desidustat is an oral, small molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor, which is used for the treatment of anemia in chronic kidney disease (CKD) patients. It is also developing an oral small molecule ZYIL1, targeted at selectively suppressing inflammation caused by the NLRP3 inflammasome. Its ZyCoV-D is a plasmid deoxyribonucleic acid (DNA) vaccine for COVID-19.;
Parent OrganisationZydus Lifesciences
Managing DirectorDr. Sharvil Patel
NSE SymbolZYDUSLIFE

Shareholding Pattern

Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Promoters
74.99%
Foreign Institutions
7.32%
Retail And Others
6.68%
Mutual Funds
6.36%
Other Domestic Institutions
4.64%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
37.00
Cipla
NA
(0.00%)
23.39
Dr Reddy's Laboratories
NA
(0.00%)
19.87
Mankind Pharma
NA
(0.00%)
49.08